The Illinois Biotechnology Innovation Organization (iBIO) will be hosting a CLE breakfast on "The Influence of PTAB Proceedings on Bio/Pharma Patents" on June 19, 2018 at Horizon Pharma Inc. in Lake Forest, IL. Paula S. Fritsch and Alison J. Baldwin of McDonnell Boehnen Hulbert & Berghoff LLP will discuss the following topics:
• A review of how bio/pharma patents have fared before the PTAB;
• An analysis of how PTAB proceedings are impacting ANDA and biosimilar litigations;
• A discussion of strategies for petitioners and patent owners in IPRs and PGRs challenging bio/pharma patents; and
• A discussion of how the Supreme Court’s recent to grant cert in Oil States and SAS decisions could impact PTAB invalidity proceedings in the bio/pharma space.
Additional information regarding the program can be found here. The registration fee for the program is $28.45 (non-members); there is no registration fee for iBIO members. Those interested in registering for the conference can do so here.
Comments